Study heart scan and function in people with Friedreich’s ataxia
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study uses heart tests (including ultrasound and MRI) to better understand how Friedreich’s ataxia affects the heart. You might benefit by getting detailed heart evaluation and contributing to research that could guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 12 to 50 if you have Friedreich’s ataxia (or 12 to 30 for healthy comparison people)
- Have a confirmed diagnosis of Friedreich’s ataxia (for the FRDA group)
- Be able to have an echocardiogram (heart ultrasound) showing ejection fraction over 35%
- No signs of heart failure and no moderate-to-severe heart rhythm problems
- Be able to get a heart MRI with contrast (or can manage claustrophobia)
- Not be pregnant (and avoid diabetes: type 1 or type 2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two brain chemicals (GABA and glutathione) in children and teens aged 8–15 with Friedreich's ataxia, a rare genetic condition affecting movement and coordination. The research aims to understand how these chemicals change in the brain and may help guide future treatments.
This study looks at how the heart works during exercise and how that relates to fatigue in people with Friedreich's ataxia. You'll ride a stationary bike, and we'll measure your heart's output to understand fatigue better.
This study tests a new medicine called GV101 to see if it can help people with Friedreich's ataxia, a condition that affects movement and balance. The trial will check if GV101 is safe and if it improves symptoms.
This study looks at “biomarkers” (measurable signs in the body, like test results from blood or other checks) in people with Friedreich’s ataxia. It may help researchers understand the disease better and track changes over time.
This study uses an EEG (a painless test that records your brain's electrical activity) to map the brain connections in people with Friedreich's ataxia. It aims to better understand how the condition affects the brain.
This trial tests a one-time gene therapy that delivers a corrected copy of the frataxin gene directly to the heart. It aims to improve or stabilize heart function in people with Friedreich's ataxia who have early or advanced heart involvement.
Hear when a new Friedreich's Ataxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.